Published by
@ShahidNShah
@ShahidNShah
September 12 to September 14, 2023
The Bostonian Boston, 26 North Street, Boston, Massachusetts, 02109, United States
The 3rd Annual Mitochondria-Related Drug Development Summit returns for the first in-person meeting of 80+ industry experts to explore the unique opportunities of targeting mitochondrial dysfunction in rare and prevalent diseases. This September, unlock the breakthroughs in our understanding of mitochondrial biology, structure, and function, to accelerate drug development. Recent IND approvals and clinical successes prove the near-endless potential of mitochondria to treat cardiovascular, renal, and neurodegenerative diseases. Join us as we bring together rare mitochondrial disease experts and prevalent disease drug developers for a new era of targeting mitochondrial dysfunction.
Read on mitochondria-drug-development.com
Continue reading at mitochondria-drug-development.com
September 13 to September 14, 2023
Sheraton Boston Hotel, 39 Dalton Street, Boston, Massachusetts, 02199, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 19, 2024 at 8:35am